Hancock Whitney’s AstraZeneca AZN Stock Holding History

Hancock Whitney’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	9,155 +1,285	+16%	+$242K	0.03%	348
2026 Q1	$1.47M	Sell	7,870 -270	-3%	-$52.1K	0.03%	366
2025 Q4	$1.5M	Sell	8,140 -458	-5%	-$80.3K	0.03%	344
2025 Q3	$1.32M	Buy	8,598 +150	+2%	+$22.7K	0.02%	363
2025 Q2	$1.18M	Buy	8,448 +2,943	+53%	+$412K	0.02%	387
2025 Q1	$809K	Buy	5,505 +131	+2%	+$19K	0.03%	350
2024 Q4	$704K	Buy	5,374 +49	+0.9%	+$6.86K	0.02%	369
2024 Q3	$830K	Sell	5,325 -76	-1%	-$12.3K	0.03%	345
2024 Q2	$842K	Buy	5,401 +777	+17%	+$117K	0.03%	334
2024 Q1	$627K	Sell	4,624 -193	-4%	-$25.6K	0.02%	382
2023 Q4	$649K	Buy	4,817 +373	+8%	+$48.5K	0.02%	391
2023 Q3	$602K	Sell	4,444 -232	-5%	-$31.7K	0.02%	382
2023 Q2	$669K	Buy	4,676 +500	+12%	+$73.6K	0.03%	379
2023 Q1	$579K	Sell	4,176 -280	-6%	-$37.7K	0.02%	402
2022 Q4	$604K	Buy	4,456 +367	+9%	+$46K	0.02%	390
2022 Q3	$449K	Buy	4,089 +614	+18%	+$77.9K	0.02%	433
2022 Q2	$459K	Buy	3,475 +33	+1%	+$4.33K	0.02%	439
2022 Q1	$457K	Sell	3,442 -244	-7%	-$29.3K	0.02%	488
2021 Q4	$429K	Buy	3,686 +439	+14%	+$51.7K	0.01%	510
2021 Q3	$390K	Buy	3,247 +233	+8%	+$27.1K	0.01%	526
2021 Q2	$361K	Buy	+3,014	New	+$331K	0.01%	637

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hancock Whitney's AZN Position: Q2 2026 in Review

Hancock Whitney increased its AstraZeneca (AZN) stake by 16% in Q2 2026, buying an estimated $242K and bringing the position to 9,155 shares worth $1.74M. The position accounts for 0.03% of the portfolio, ranked #348.

Hancock Whitney first reported a position in AZN in Q2 2021 and has held it in 21 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Hancock Whitney held 9,155 shares of AstraZeneca worth $1.74M as of Q2 2026.
Hancock Whitney bought 1,285 AstraZeneca shares in Q2 2026, an estimated $242K.
AstraZeneca made up 0.03% of Hancock Whitney's portfolio in Q2 2026, its #348 holding.
Hancock Whitney first reported a position in AstraZeneca in Q2 2021 and has held it in 21 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.